Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Naldemedine (S-297995) for the Treatment of Opioid-Induced Bowel Dysfunction in Subjects With Chronic Pain [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and efficacy of naldemedine (S-297995) for treating opioid-induced bowel dysfunction in chronic pain patients; the trial is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-induced Bowel Dysfunction

Drugs mentioned

• Naldemedine (naldemedine)

Snippet

Sponsor: Shionogi | Conditions: Opioid Induced Bowel Dysfunction | Phase 2 | Status: COMPLETED | Results posted: 2017-05-30